Pneumologia Vol. 67 Nr. 3
Journal indexed in SCOPUS and EBSCO
Member of COPE
Impact factor SJR 0.145
Copyright Romanian Society of Pneumology
We want to make exchanges with other publications.
Combustible cigarette smoking is the most attributable and preventable risk factor for adult mortality and morbid-ity in Romania and worldwide. Among health professionals, there is a paradoxically high prevalence of smokers in most European countries. Doctors need always to be health role models. As future physicians, medical students represent a primary target for tobacco-prevention programs, but they are also victims of the tobacco industry.
Bronchiectasis has been a neglected disease for dec-ades. However, in the past years, a continuous interest for this area of respiratory medicine has been observed.
Idiopathic pulmonary fibrosis (IPF) is a rare and severe disease that belongs to the vast group of interstitial lung diseases (ILD), generally described as acute and chronic bilateral parenchyma infiltrative lung diseases, with vari-able degrees of tissue inflammation and fibrosis, when they occur in immune-competent hosts without infection or neoplasm(1).
Based on the assumption that pressure in the adja-cent pleura is transmitted to the esophagus, esophageal pressure (Pes) monitoring, a minimally invasive respira-tory method that has been used for decades (for the first time in 1949), has proved to be an accurate estimate of pleural pressure and consequently of transpulmonary pressure(1).
Chronic obstructive pulmonary disease (COPD) is the fourth cause of mortality worldwide. It is a disease with increas-ing prevalence, that generates high social and economic costs(1,2).
Pulmonary lymphangitic carcinomatosis (PLC) is a metastatic lung disease characterised by the diffuse infiltration and obstruction of the pulmonary paren-chymal lymphatic system by tumor cells(2,3). PLC is most commonly seen secondary to adenocarcinomas of breast, lung, stomach, colon, thyroid, prostate, and cervicx.
Idiopathic pulmonary fibrosis (IPF) is a rare disease, still it is the most prevalent of all idiopathic interstitial lung diseases (ILDs). IPF is a devastating disease: the development of scar tissue in the parenchyma of the lungs impairs the capacity of the lungs to do their main job in the body, that is to provide oxygen to the blood.
On the occasion of the World No Tobacco Day (initiated by the World Health Organization in 1987), the Romanian Society of Cardiology, the Romanian Society of Pneumology, and the Romanian Heart Foundation, in the forefront of the fight against smoking in Romania, are launching a new appeal to authorities and the public: “Tobacco destroys hearts!” It was a milestone first marked by a round table meeting with lawmakers, authorities and patient NGOs, followed by a press conference.
Prof. Dr. Emilia Crișan – Ph.D, beloved daughter, wife, mother and grandmother – passed away.